Veradermics, Inc

MANE NYSE CIK: 0001827635

Company Information

Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting companyEmerging growth company
State of Incorporation DE
Business Address 470 JAMES STREET, NEW HAVEN, CT, 06513
Mailing Address 470 JAMES STREET, NEW HAVEN, CT, 06513
Phone 228.372.3376
Fiscal Year End 1231
EIN 843304423

Financial Overview

FY2025

-$26.49M
Net Income
$152.62M
Total Assets
$9.16M
Total Liabilities
-$22.24M
Stockholders' Equity
$53.08M
Cash & Equivalents
$-37.05
EPS

Recent SEC Filings

Form Type Date Filed Document
10-K Annual financial report March 30, 2026 View on SEC
8-K Current report of material events March 30, 2026 View on SEC
4/A Insider transaction amendment February 27, 2026 View on SEC
SCHEDULE 13G Passive beneficial ownership (>5%) February 12, 2026 View on SEC
SCHEDULE 13D Beneficial ownership report (>5%) February 12, 2026 View on SEC
SCHEDULE 13D Beneficial ownership report (>5%) February 11, 2026 View on SEC
SCHEDULE 13D Beneficial ownership report (>5%) February 11, 2026 View on SEC
4 Insider stock transaction report February 9, 2026 View on SEC
3 Initial insider ownership report February 9, 2026 View on SEC
4 Insider stock transaction report February 5, 2026 View on SEC

IPO Filings

S-1 January 9, 2026
  • Developing brand-new, innovative medicines specifically for severe skin conditions using cutting-edge science.
  • Showing promising growth with key drugs already on the market and new treatments in development.
View Analysis

Annual Reports

10-K March 30, 2026
  • Developing VDPHL01, a non-hormonal oral pill for pattern hair loss.
  • Promising pilot study results with 90.5% of men showing improved hair coverage.
View Analysis

Insider Trading

STRONG BUY 5 insiders 27 recent transactions
View Full Insider Trading Profile

Related Companies

Companies in the same industry (SIC: 2834)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.